On Monday, Following Stocks were among the “Top 100 Gainers” of U.S. Stock Market: ImmunoGen, Inc. (NASDAQ:IMGN), CyberArk Software, Ltd. (NASDAQ:CYBR), Cliffs Natural Resources Inc. (NYSE:CLF), Callaway Golf Co. (NYSE:ELY)
ImmunoGen, Inc. (NASDAQ:IMGN), with shares inclined 16.80%, closed at $8.69.
CyberArk Software, Ltd. (NASDAQ:CYBR), with shares jumped 12.73%, settled at $54.89.
Cliffs Natural Resources Inc. (NYSE:CLF), with shares climbed 11.86%, and closed at $4.81.
Callaway Golf Co. (NYSE:ELY), surged 11.31%, and closed at $9.55.
Latest NEWS regarding these Stocks are depicted underneath:
ImmunoGen, Inc. (NASDAQ:IMGN)
Takeda Pharmaceutical Corporation Limited (TSE:4502) and ImmunoGen, Inc. (IMGN), a biotechnology corporation that develops targeted anticancer therapeutics using its state-of-the-art antibody-drug conjugate (ADC) technology, declared that Takeda has licensed exclusive rights to use ImmunoGen’s ADC technology – counting ImmunoGen’s new DNA-acting IGN payload agents – to develop and commercialize targeted anticancer therapeutics to up to two unrevealed targets. The contract also provides Takeda with the option to take a license for a third target for an additional upfront fee.
ImmunoGen will receive $20 million upfront and – for each target – is eligible to receive milestone payments potentially totaling up to $210 million plus royalties on the commercial net sales of any resulting ADC products. Takeda is responsible for the development, manufacturing and marketing of any ADC products resulting from this contract.
Takeda signed an contract with ImmunoGen through its wholly owned partner, Millennium Pharmaceuticals, Inc.
ImmunoGen is not updating its guidance for its 2015 fiscal year at this time.
ImmunoGen, Inc., a biotechnology corporation, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. The corporation offers Kadcyla, an antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer. Its product candidates comprise IMGN853, which is in Phase I clinical trials for the treatment of ovarian cancer, endometrial cancer, and other cancers; IMGN289 that is in Phase I clinical trials for treating squamous cell carcinoma of head and neck cancer, and non-small cell lung cancer; IMGN529, which is in Phase I clinical trials for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia; and IMGN779 that is in preclinical stage for treating acute myeloid leukemia.
CyberArk Software, Ltd. (NASDAQ:CYBR)
CyberArk Software, Ltd. (CYBR), the corporation that protects organizations from cyber attacks that have made their way inside the network perimeter, declared that it was named a leader in the IDC MarketScape: Worldwide Privileged Access Administration 2014 Vendor Assessment (doc #253303, December 2014).
The IDC MarketScape assesses vendors offering products in the privileged access administration (PAM) market and notes that, “CyberArk is the PAM pure-play “big gorilla” with the most proceed and largest customer base.”
The compromise and misuse of privileged accounts is a key signature in advanced, targeted cyber attacks. As demonstrated in recent, devastating attacks on businesses, cyber attackers steal and exploit privileged accounts to conduct a hostile takeover of a corporation’s entire infrastructure. By exploiting privileged access, attackers can conduct internal reconnaissance, move laterally throughout a network without detection and complete the aims of the attack. The IDC MarketScape recognizes the critical need of securing privileged accounts and provides businesses with recommendations for evaluating vendors.
The IDC MarketScape report highlights the key functionality businesses should consider when selecting a privileged access administration provider, counting the ability to:
- Manage access to shared accounts with sensitive privileges: This comprises tracking any shared account usage by controlling password access and logging user activity for anomalous behavior.
- Remove Windows local administrative functionality: By removing the local administrator privilege from the user account and providing flexibility and functionality for a user’s particular needs, IT can better support individual job needs while protecting against today’s malware threats that target these admin accounts.
- Enhance visibility of sensitive account activity: Third-party accounts are often shared intentionally or unintentionally among users outside an organization, making them extremely difficult to monitor. With proper PAM solutions in place, visibility into account activity can be elevated beyond basic capabilities for a full view of the network.
- Restrict privileges for separation of duties: To minimize the potential for a single user to compromise the system, organizations should implement solutions that provide separation of duties and therefore force the need for partnership among attackers to compromise a system.
- Manage embedded application and service accounts: Distributed architectures often require some way to establish a presence on a set of resources and embedding static accounts and passwords has been a very ordinary solution. Organizations must manage, protect and secure these accounts, as they pose a noteworthy security risk.
CyberArk Software Ltd. develops, markets, and sells software-based IT security solutions that protect organizations from cyber attacks in the United States and internationally. The corporation offers privileged account security solution to secure, manage, and monitor privileged account access and activities.
Cliffs Natural Resources Inc. (NYSE:CLF)
Noront Resources Ltd. (TSX VENTURE: NOT) has reached an contract to attain, among other things, the shares of Cliffs Chromite Ontario Inc. and Cliffs Chromite Far North Inc., both indirect wholly owned auxiliaries of Cliffs Natural Resources Inc. (CLF), which hold mining claims in the Ring of Fire mining district, for an attainment price of US$20 million.
The Transaction comprises the attainment of about 103 claims presently owned by CCOI and CCFNI, counting: a 100% interest in the Black Thor chromite deposit; a 100% interest in the Black Label chromite deposit; and, a 70% interest in the Big Daddy chromite deposit. It also gives Noront 85% ownership of the McFauld’s Lake copper zinc resource.
Upon closing, Noront will hold a total of about 360 mining claims and roughly 65% (80,000 hectares) of the emerging mining camp known as the Ring of Fire, located 500 kilometres northeast of Thunder Bay. These additional assets, alongside Noront’s existing Eagle’s Nest nickel-copper-platinum group element deposit and its Blackbird chromite deposit will allow Noront to further its vision of becoming the leading resource corporation in the area.
Noront Resources Ltd. is focused on development of the high-grade Eagle’s Nest nickel, copper, platinum and palladium deposit and the high-grade Blackbird chromite deposit, both of which are located in the James Bay Lowlands of Ontario in an emerging metals camp known as the Ring of Fire.
Cliffs Natural Resources Inc., a mining and natural resources corporation, produces iron ore and metallurgical coal. It operates five iron ore mines that produces iron ore pellets in Michigan and Minnesota; Koolyanobbing complex situated in northeast of the town of Southern Cross, which produces lump and fines iron ore; and two metallurgical coal mines located in Alabama and West Virginia.
Callaway Golf Co. (NYSE:ELY)
On Monday Morning, Callaway Golf Co. (ELY), was upgraded by Imperial Capital Research firm. The rating is transferred from “In-line” to “Outperform.”
Formerly, on 3-Oct-14, the same firm initiated its observance on the stock as “In-line” rating.
Callaway Golf Corporation, together with its auxiliaries, designs, manufactures, and sells golf clubs and balls. It offers drivers, fairway woods, hybrids, irons, wedges, and putters.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
